Katherine E. Gallagher
Keppel Street
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Determinants of measles second-dose vaccine coverage in the Gambia - a secondary analysis of 2019 demographic and health survey data.
Journal: Vaccine
Published: August 11, 2025
Determining the dose-response relationship for pneumococcal conjugate vaccines: a nested analysis of the fractional dose PCV trial.
Journal: Vaccine
Published: July 27, 2025
Pneumococcal carriage prevalence, serotype distribution, and vaccine coverage in Ethiopia 12 years after pneumococcal vaccine introduction.
Journal: Vaccine
Published: July 22, 2025
"Resilience amidst challenges": Healthcare users' experiences of access and utilisation of primary healthcare services during the COVID-19 pandemic in southwestern Uganda.
Journal: PLOS global public health
Published: May 08, 2025
Genomic and clinical epidemiology of SARS-CoV-2 in coastal Kenya: insights into variant circulation, reinfection, and multiple lineage importations during a post-pandemic wave.
Journal: BMC global and public health
Published: April 23, 2025
Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalence.
Journal: The Lancet. Microbe
Published: February 06, 2025
Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial.
Journal: The New England journal of medicine
Published: September 27, 2024
Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trial.
Journal: The Lancet. Infectious diseases
Published: August 21, 2024
Continuity and Rupture in Crisis: from Ebola to COVID-19 in Sierra Leone and the eastern Democratic Republic of the Congo.
Journal: Global public health
Published: October 03, 2023
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022.
Journal: Influenza and other respiratory viruses
Published: April 05, 2023
Symptom prevalence and secondary attack rate of SARS-CoV-2 in rural Kenyan households: A prospective cohort study.
Journal: Influenza and other respiratory viruses
Published: April 04, 2023
Last Updated: 09/26/2026